Literature DB >> 12781702

Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model.

Giovanni Matera1, Maria Carla Liberto, Angela Quirino, Giorgio Settimo Barreca, Angelo Giuseppe Lamberti, Michelangelo Iannone, Eliana Mancuso, Ernesto Palma, Francesco Antonio Cufari, Domenicantonio Rotiroti, Alfredo Focà.   

Abstract

Bartonella quintana, an emerging gram-negative pathogen, may cause trench fever, endocarditis, cerebral abscess and bacillary angiomatosis usually with the absence of septic shock in humans. B. quintana lipopolysaccharide (LPS), a deep rough endotoxin with strong reactivity in the limulus amebocyte lysate (LAL)-assay, was studied in human whole blood and in a rat model. A significant (P<0.05) increase of interleukin-8 (IL-8) concentration, comparable to the level induced by enterobacterial LPS, was stimulated in the human whole blood by B. quintana LPS. Isolated human neutrophils delayed their apoptotic behavior in the presence of B. quintana LPS. In the rat, B. quintana LPS induced a significant (P<0.001) increase in white blood cell count, both 30 and 60 min after intravenous injection. Such leukocytosis was inhibited by pretreatment with prazosin, an alpha-adrenergic antagonist. B. quintana LPS did not significantly change heart rate (HR), hematocrit (HCT) and platelet count in the above reported in vivo model, and regarding mean blood pressure (MAP) only a very early (5 min after LPS) and mild (yet significant) hypotension was observed. In contrast, a long-lasting decrease of MAP was found in Salmonella minnesota R595 LPS-treated animals. Blood TNFalpha levels did not change significantly from the baseline in rats injected with either saline or with B. quintana LPS, on the contrary S. minnesota R595 LPS-injected animals showed substantial increase of TNFalpha levels up to 2924 pg/ml at 60 min after LPS injection. B. quintana LPS as well as Salmonella LPS-injected rats exhibited an increase of the blood levels of GRO/CINC-1, particularly at 240 min after LPS administration. Apical part of rat gut villi showed several TUNEL-positive cells in tissue sections from B. quintana LPS-treated animals. Taken together, our data demonstrates that B. quintana LPS is able to selectively stimulate some inflammatory mediators. B. quintana LPS-induced leukocytosis appears mediated by an alpha-adrenergic receptor. The delayed apoptotic process of leukocytes and the chemokine increase may explain the apoptotic cells found in the rat gut and the inflammatory reactions in some human Bartonella diseases. This peculiar inflammatory pattern induced by B. quintana LPS, may partially account for the lack of severe septic shock, observed in human B. quintana infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781702     DOI: 10.1016/S1567-5769(03)00059-6

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  16 in total

1.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Effects of cow age and pregnancy on Bartonella infection in a herd of dairy cattle.

Authors:  R Maillard; B Grimard; S Chastant-Maillard; B Chomel; T Delcroix; C Gandoin; C Bouillin; L Halos; M Vayssier-Taussat; H-J Boulouis
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 3.  Bartonella Species, an Emerging Cause of Blood-Culture-Negative Endocarditis.

Authors:  Udoka Okaro; Anteneh Addisu; Beata Casanas; Burt Anderson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Bartonella and Brucella--weapons and strategies for stealth attack.

Authors:  Houchaima Ben-Tekaya; Jean-Pierre Gorvel; Christoph Dehio
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 5.  Intruders below the radar: molecular pathogenesis of Bartonella spp.

Authors:  Alexander Harms; Christoph Dehio
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  Predominant outer membrane antigens of Bartonella henselae.

Authors:  Matthew R Chenoweth; Craig E Greene; Duncan C Krause; Frank C Gherardini
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

7.  Infection of human brain vascular pericytes (HBVPs) by Bartonella henselae.

Authors:  Mrudula Varanat; Ricardo G Maggi; Keith E Linder; Edward B Breitschwerdt
Journal:  Med Microbiol Immunol       Date:  2012-11-25       Impact factor: 3.402

8.  Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4.

Authors:  Calin Popa; Shahla Abdollahi-Roodsaz; Leo A B Joosten; Nozomi Takahashi; Tom Sprong; Giovanni Matera; Maria Carla Liberto; Alfredo Foca; Marcel van Deuren; Bart Jan Kullberg; Wim B van den Berg; Jos W M van der Meer; Mihai G Netea
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

9.  Glomerulonephritis Caused by Bartonella spp. Infective Endocarditis: The Difficulty and Importance of Differentiation from Anti-neutrophil Cytoplasmic Antibody-related Rapidly Progressive Glomerulonephritis.

Authors:  Ayumi Yoshifuji; Yuuka Hibino; Motoaki Komatsu; Seiichi Yasuda; Koji Hosoya; Emi Kobayashi; Yuko Baba; Shigemichi Hirose; Akinori Hashiguchi; Yoshihiko Kanno; Munekazu Ryuzaki
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

Review 10.  Bartonella infection in immunocompromised hosts: immunology of vascular infection and vasoproliferation.

Authors:  Mosepele Mosepele; Dana Mazo; Jennifer Cohn
Journal:  Clin Dev Immunol       Date:  2011-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.